Korean Market
EXCH
Aribio Lab
★

Extraordinary General Meeting Called: Articles Amendment, Full Board and Auditor Replacement, Business Expansion

 
EXCH
Aribio Lab
★★

Largest Shareholder SORUX Repays 6.3B Won Loan, Releases 3.95M Shares Pledge – Risk Mitigation

 
MATR
Aribio Lab
★

Aribio Lab's 5 Billion Won Third-Party Allotment to Dream High Holdings Raises Dilution and Counterparty Risk Concerns

 
MATR
CHA Vaccine Research Institute
★

CHA Vaccine Research Institute Decides to Issue 6th Series Convertible Bonds Worth 4 Billion KRW… Conversion Price at 3,210 KRW, Risk of Dilution and Collateral Pledge

 
PERI
CHA Vaccine Research Institute
★

Aribio Lab (fka CHA Vaccine) Quarterly Report: Name Change and Charter Amendment Raise Dilution Concerns, Continued Losses

 
EXCH
CHA Vaccine Research Institute
★

Appointment of Managing Director

 
MATR
CHA Vaccine Research Institute
★

Convertible Bond Issuance Decision - Including Put and Call Options

 
OWNR
CHA Vaccine Research Institute
★

Submission of Large Shareholding Report (No Content)

 
OWNR
CHA Vaccine Research Institute
★

Large Shareholding Report (Abbreviated) Filed - No Specific Figures

 
OWNR
CHA Vaccine Research Institute
★

Filing of Large Shareholding Report (Pure Investment Purpose)

 
OWNR
CHA Vaccine Research Institute
★

Substantial Shareholding Report Filed - Largest Shareholder KH Green 9.35%

 
OWNR
CHA Vaccine Research Institute
★

Cha Biotech Files Report on Ownership of Specific Securities by Executives and Major Shareholders

 
EXCH
CHA Vaccine Research Institute
★★

Acquisition of KRW 2.8 Billion Convertible Bonds from Affiliate Aribio

 
OTHR
CHA Vaccine Research Institute
★

Report on Change of Outside Directors (No Details Provided)

 
EXCH
CHA Vaccine Research Institute
★

EGM Results - Articles Amendment and Director Elections Approved as Proposed